Vericel (VCEL) 10-K2022 FY Annual report

Filed: 23 Feb 23, 9:03am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: advice, alan, alert, altogether, antibacterial, antimicrobial, bear, bedside, begun, benchmarked, BioCartilage, blockade, blood, cap, CartiMax, CBC, CCO, CDER, Chairman, Chase, climate, clostridial, collagenase, Colorado, commodity, commonplace, ConMed, Connecticut, consecutive, countermeasure, coupled, covenant, default, degrade, deletion, deployment, depth, destruction, diem, dissolved, downstream, dressing, duly, East, embargo, embroiled, energy, enjoy, entrant, erased, escalation, expertise, family, feedback, fibrocartilage, filler, film, floating, footprint, FTC, Furnished, gas, gel, geopolitical, gilman, globe, granulation, greenhouse, hagen, headquartered, heidi, herewith, hydrosurgery, IITM, inefficient, inflammation, inflationary, influence, ingredient, inquiring, instability, intangible, intensify, intermittent, investigatory, IRA, JPMorgan, kevin, landmark, landscape, Language, leakage, legitimized, lessened, Leverage, leveraged, literature, lyophilized, maximum, mclaughlin, mechanism, merge, Middle, militant, morbidity, neighboring, nineteenth, notice, occupy, ointment, ordinary, Palestinian, paul, paving, petrolatum, PHSA, pineapple, placement, plc, postoperative, powder, prepay, progression, proper, Ratio, readily, repay, resurfacing, robert, rubino, Russia, Russian, scarring, scraping, sharp, siegal, silver, slicing, sloughing, soaked, Society, SOFR, solution, SP, steadily, sterile, steven, strict, strive, subordinated, sulfadiazine, terrorist, thereunto, thirty, trailing, treatable, Ukraine, unapproved, underpaid, undersigned, underway, undiscounted, unify, Utah, vehicular, Versajet, vi, vii, viii, voice, voluntarily, vowed, vulnerability, waning, war, wotton, zerbe

Removed: achieving, Allogeneic, auto, automatic, concealed, discovered, disqualification, enzymatically, exceeding, goodwill, hybrid, indefinitely, institute, judge, leasing, mask, massive, Mexico, mismatch, month, Mustard, nonviable, occurring, participate, positioned, practicing, repealed, researcher, restricting, Simplifying, subsidiary, suggest, Sulfur, thereof, undetected

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated VCEL transcripts

VCEL similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Vericel Corporation (Company) on Form 10-K for the year ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (Report), each of the undersigned officers of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 906), the following:

(1) The Report fully complies with the requirements of section 13(a) and 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date:	February 23, 2023

		/s/ DOMINICK C. COLANGELO
		Dominick C. Colangelo
		President and Chief Executive Officer
		(Principal Executive Officer)

		/s/ JOSEPH MARA
		Joseph Mara
		Chief Financial Officer
		(Principal Financial Officer)

A signed original of this written statement required by Section 906 has been provided to Vericel Corporation and will be retained by Vericel Corporation and furnished to the Securities and Exchange Commission or its staff upon request.